Long term follow-up (F/U) from SWOG 8269: concurrent cisplatin (P), etoposide (E), vincristine (V) and daily thoracic radiotherapy (TRT) for the treatment of limited small-cell lung cancer (LSCLC): patterns of failure and second tumors : A Turrisi, D Rector, LM Janaki, JD McCracken, R Livingston, SP Giri, W Gordon, and J Crowley. from the Southwest Oncology Group, San Antonio, Texas, USA
- 30 June 1994
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 11, 172
- https://doi.org/10.1016/0169-5002(94)94439-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: